Global Dermatology Drug Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
Summary
Dermatology Drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases.
According to APO Research, The global Dermatology Drug market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Dermatology Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Dermatology Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Dermatology Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Dermatology Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Dermatology Drug include AbbVie, Johnson & Johnson, Bayer, Galderma, Bristol-Myers Squibb, Novartis, Pfizer, Merz Pharma and Valeant, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Dermatology Drug, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Dermatology Drug, also provides the value of main regions and countries. Of the upcoming market potential for Dermatology Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Dermatology Drug revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Dermatology Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Dermatology Drug company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Dermatology Drug segment by Company
1. To analyze and research the global Dermatology Drug status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Dermatology Drug key companies, revenue, market share, and recent developments.
3. To split the Dermatology Drug breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Dermatology Drug market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Dermatology Drug significant trends, drivers, influence factors in global and regions.
6. To analyze Dermatology Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dermatology Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dermatology Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dermatology Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Dermatology Drug industry.
Chapter 3: Detailed analysis of Dermatology Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Dermatology Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Dermatology Drug in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
Dermatology Drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases.
According to APO Research, The global Dermatology Drug market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Dermatology Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Dermatology Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Dermatology Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Dermatology Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Dermatology Drug include AbbVie, Johnson & Johnson, Bayer, Galderma, Bristol-Myers Squibb, Novartis, Pfizer, Merz Pharma and Valeant, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Dermatology Drug, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Dermatology Drug, also provides the value of main regions and countries. Of the upcoming market potential for Dermatology Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Dermatology Drug revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Dermatology Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Dermatology Drug company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Dermatology Drug segment by Company
- AbbVie
- Johnson & Johnson
- Bayer
- Galderma
- Bristol-Myers Squibb
- Novartis
- Pfizer
- Merz Pharma
- Valeant
- LEO Pharma
- GlaxoSmithKline
- External Use
- Oral
- Injection
- Psoriasis
- Skin Infections
- Acne
- Dermatitis
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global Dermatology Drug status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Dermatology Drug key companies, revenue, market share, and recent developments.
3. To split the Dermatology Drug breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Dermatology Drug market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Dermatology Drug significant trends, drivers, influence factors in global and regions.
6. To analyze Dermatology Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dermatology Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dermatology Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dermatology Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Dermatology Drug industry.
Chapter 3: Detailed analysis of Dermatology Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Dermatology Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Dermatology Drug in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Dermatology Drug Market Size, 2019 VS 2023 VS 2030
1.3 Global Dermatology Drug Market Size (2019-2030)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 DERMATOLOGY DRUG MARKET DYNAMICS
2.1 Dermatology Drug Industry Trends
2.2 Dermatology Drug Industry Drivers
2.3 Dermatology Drug Industry Opportunities and Challenges
2.4 Dermatology Drug Industry Restraints
3 DERMATOLOGY DRUG MARKET BY COMPANY
3.1 Global Dermatology Drug Company Revenue Ranking in 2023
3.2 Global Dermatology Drug Revenue by Company (2019-2024)
3.3 Global Dermatology Drug Company Ranking, 2022 VS 2023 VS 2024
3.4 Global Dermatology Drug Company Manufacturing Base & Headquarters
3.5 Global Dermatology Drug Company, Product Type & Application
3.6 Global Dermatology Drug Company Commercialization Time
3.7 Market Competitive Analysis
3.7.1 Global Dermatology Drug Market CR5 and HHI
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.7.3 2023 Dermatology Drug Tier 1, Tier 2, and Tier
3.8 Mergers & Acquisitions, Expansion
4 DERMATOLOGY DRUG MARKET BY TYPE
4.1 Dermatology Drug Type Introduction
4.1.1 External Use
4.1.2 Oral
4.1.3 Injection
4.2 Global Dermatology Drug Sales Value by Type
4.2.1 Global Dermatology Drug Sales Value by Type (2019 VS 2023 VS 2030)
4.2.2 Global Dermatology Drug Sales Value by Type (2019-2030)
4.2.3 Global Dermatology Drug Sales Value Share by Type (2019-2030)
5 DERMATOLOGY DRUG MARKET BY APPLICATION
5.1 Dermatology Drug Application Introduction
5.1.1 Psoriasis
5.1.2 Skin Infections
5.1.3 Acne
5.1.4 Dermatitis
5.1.5 Others
5.2 Global Dermatology Drug Sales Value by Application
5.2.1 Global Dermatology Drug Sales Value by Application (2019 VS 2023 VS 2030)
5.2.2 Global Dermatology Drug Sales Value by Application (2019-2030)
5.2.3 Global Dermatology Drug Sales Value Share by Application (2019-2030)
6 DERMATOLOGY DRUG MARKET BY REGION
6.1 Global Dermatology Drug Sales Value by Region: 2019 VS 2023 VS 2030
6.2 Global Dermatology Drug Sales Value by Region (2019-2030)
6.2.1 Global Dermatology Drug Sales Value by Region: 2019-2024
6.2.2 Global Dermatology Drug Sales Value by Region (2025-2030)
6.3 North America
6.3.1 North America Dermatology Drug Sales Value (2019-2030)
6.3.2 North America Dermatology Drug Sales Value Share by Country, 2023 VS 2030
6.4 Europe
6.4.1 Europe Dermatology Drug Sales Value (2019-2030)
6.4.2 Europe Dermatology Drug Sales Value Share by Country, 2023 VS 2030
6.5 Asia-Pacific
6.5.1 Asia-Pacific Dermatology Drug Sales Value (2019-2030)
6.5.2 Asia-Pacific Dermatology Drug Sales Value Share by Country, 2023 VS 2030
6.6 Latin America
6.6.1 Latin America Dermatology Drug Sales Value (2019-2030)
6.6.2 Latin America Dermatology Drug Sales Value Share by Country, 2023 VS 2030
6.7 Middle East & Africa
6.7.1 Middle East & Africa Dermatology Drug Sales Value (2019-2030)
6.7.2 Middle East & Africa Dermatology Drug Sales Value Share by Country, 2023 VS 2030
7 DERMATOLOGY DRUG MARKET BY COUNTRY
7.1 Global Dermatology Drug Sales Value by Country: 2019 VS 2023 VS 2030
7.2 Global Dermatology Drug Sales Value by Country (2019-2030)
7.2.1 Global Dermatology Drug Sales Value by Country (2019-2024)
7.2.2 Global Dermatology Drug Sales Value by Country (2025-2030)
7.3 USA
7.3.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.3.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.3.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.4 Canada
7.4.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.4.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.4.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.5 Germany
7.5.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.5.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.6 France
7.6.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.6.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.7 U.K.
7.7.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.7.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.8 Italy
7.8.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.8.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.9 Netherlands
7.9.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.9.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.10 Nordic Countries
7.10.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.10.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.11 China
7.11.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.11.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.12 Japan
7.12.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.12.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.13 South Korea
7.13.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.13.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.14 Southeast Asia
7.14.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.14.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.15 India
7.15.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.15.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.16 Australia
7.16.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.16.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.17 Mexico
7.17.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.17.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.18 Brazil
7.18.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.18.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.19 Turkey
7.19.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.19.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.20 Saudi Arabia
7.20.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.20.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.21 UAE
7.21.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.21.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 AbbVie
8.1.1 AbbVie Comapny Information
8.1.2 AbbVie Business Overview
8.1.3 AbbVie Dermatology Drug Revenue and Gross Margin (2019-2024)
8.1.4 AbbVie Dermatology Drug Product Portfolio
8.1.5 AbbVie Recent Developments
8.2 Johnson & Johnson
8.2.1 Johnson & Johnson Comapny Information
8.2.2 Johnson & Johnson Business Overview
8.2.3 Johnson & Johnson Dermatology Drug Revenue and Gross Margin (2019-2024)
8.2.4 Johnson & Johnson Dermatology Drug Product Portfolio
8.2.5 Johnson & Johnson Recent Developments
8.3 Bayer
8.3.1 Bayer Comapny Information
8.3.2 Bayer Business Overview
8.3.3 Bayer Dermatology Drug Revenue and Gross Margin (2019-2024)
8.3.4 Bayer Dermatology Drug Product Portfolio
8.3.5 Bayer Recent Developments
8.4 Galderma
8.4.1 Galderma Comapny Information
8.4.2 Galderma Business Overview
8.4.3 Galderma Dermatology Drug Revenue and Gross Margin (2019-2024)
8.4.4 Galderma Dermatology Drug Product Portfolio
8.4.5 Galderma Recent Developments
8.5 Bristol-Myers Squibb
8.5.1 Bristol-Myers Squibb Comapny Information
8.5.2 Bristol-Myers Squibb Business Overview
8.5.3 Bristol-Myers Squibb Dermatology Drug Revenue and Gross Margin (2019-2024)
8.5.4 Bristol-Myers Squibb Dermatology Drug Product Portfolio
8.5.5 Bristol-Myers Squibb Recent Developments
8.6 Novartis
8.6.1 Novartis Comapny Information
8.6.2 Novartis Business Overview
8.6.3 Novartis Dermatology Drug Revenue and Gross Margin (2019-2024)
8.6.4 Novartis Dermatology Drug Product Portfolio
8.6.5 Novartis Recent Developments
8.7 Pfizer
8.7.1 Pfizer Comapny Information
8.7.2 Pfizer Business Overview
8.7.3 Pfizer Dermatology Drug Revenue and Gross Margin (2019-2024)
8.7.4 Pfizer Dermatology Drug Product Portfolio
8.7.5 Pfizer Recent Developments
8.8 Merz Pharma
8.8.1 Merz Pharma Comapny Information
8.8.2 Merz Pharma Business Overview
8.8.3 Merz Pharma Dermatology Drug Revenue and Gross Margin (2019-2024)
8.8.4 Merz Pharma Dermatology Drug Product Portfolio
8.8.5 Merz Pharma Recent Developments
8.9 Valeant
8.9.1 Valeant Comapny Information
8.9.2 Valeant Business Overview
8.9.3 Valeant Dermatology Drug Revenue and Gross Margin (2019-2024)
8.9.4 Valeant Dermatology Drug Product Portfolio
8.9.5 Valeant Recent Developments
8.10 LEO Pharma
8.10.1 LEO Pharma Comapny Information
8.10.2 LEO Pharma Business Overview
8.10.3 LEO Pharma Dermatology Drug Revenue and Gross Margin (2019-2024)
8.10.4 LEO Pharma Dermatology Drug Product Portfolio
8.10.5 LEO Pharma Recent Developments
8.11 GlaxoSmithKline
8.11.1 GlaxoSmithKline Comapny Information
8.11.2 GlaxoSmithKline Business Overview
8.11.3 GlaxoSmithKline Dermatology Drug Revenue and Gross Margin (2019-2024)
8.11.4 GlaxoSmithKline Dermatology Drug Product Portfolio
8.11.5 GlaxoSmithKline Recent Developments
9 CONCLUDING INSIGHTS
10 APPENDIX
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
1.1 Product Definition
1.2 Global Dermatology Drug Market Size, 2019 VS 2023 VS 2030
1.3 Global Dermatology Drug Market Size (2019-2030)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 DERMATOLOGY DRUG MARKET DYNAMICS
2.1 Dermatology Drug Industry Trends
2.2 Dermatology Drug Industry Drivers
2.3 Dermatology Drug Industry Opportunities and Challenges
2.4 Dermatology Drug Industry Restraints
3 DERMATOLOGY DRUG MARKET BY COMPANY
3.1 Global Dermatology Drug Company Revenue Ranking in 2023
3.2 Global Dermatology Drug Revenue by Company (2019-2024)
3.3 Global Dermatology Drug Company Ranking, 2022 VS 2023 VS 2024
3.4 Global Dermatology Drug Company Manufacturing Base & Headquarters
3.5 Global Dermatology Drug Company, Product Type & Application
3.6 Global Dermatology Drug Company Commercialization Time
3.7 Market Competitive Analysis
3.7.1 Global Dermatology Drug Market CR5 and HHI
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.7.3 2023 Dermatology Drug Tier 1, Tier 2, and Tier
3.8 Mergers & Acquisitions, Expansion
4 DERMATOLOGY DRUG MARKET BY TYPE
4.1 Dermatology Drug Type Introduction
4.1.1 External Use
4.1.2 Oral
4.1.3 Injection
4.2 Global Dermatology Drug Sales Value by Type
4.2.1 Global Dermatology Drug Sales Value by Type (2019 VS 2023 VS 2030)
4.2.2 Global Dermatology Drug Sales Value by Type (2019-2030)
4.2.3 Global Dermatology Drug Sales Value Share by Type (2019-2030)
5 DERMATOLOGY DRUG MARKET BY APPLICATION
5.1 Dermatology Drug Application Introduction
5.1.1 Psoriasis
5.1.2 Skin Infections
5.1.3 Acne
5.1.4 Dermatitis
5.1.5 Others
5.2 Global Dermatology Drug Sales Value by Application
5.2.1 Global Dermatology Drug Sales Value by Application (2019 VS 2023 VS 2030)
5.2.2 Global Dermatology Drug Sales Value by Application (2019-2030)
5.2.3 Global Dermatology Drug Sales Value Share by Application (2019-2030)
6 DERMATOLOGY DRUG MARKET BY REGION
6.1 Global Dermatology Drug Sales Value by Region: 2019 VS 2023 VS 2030
6.2 Global Dermatology Drug Sales Value by Region (2019-2030)
6.2.1 Global Dermatology Drug Sales Value by Region: 2019-2024
6.2.2 Global Dermatology Drug Sales Value by Region (2025-2030)
6.3 North America
6.3.1 North America Dermatology Drug Sales Value (2019-2030)
6.3.2 North America Dermatology Drug Sales Value Share by Country, 2023 VS 2030
6.4 Europe
6.4.1 Europe Dermatology Drug Sales Value (2019-2030)
6.4.2 Europe Dermatology Drug Sales Value Share by Country, 2023 VS 2030
6.5 Asia-Pacific
6.5.1 Asia-Pacific Dermatology Drug Sales Value (2019-2030)
6.5.2 Asia-Pacific Dermatology Drug Sales Value Share by Country, 2023 VS 2030
6.6 Latin America
6.6.1 Latin America Dermatology Drug Sales Value (2019-2030)
6.6.2 Latin America Dermatology Drug Sales Value Share by Country, 2023 VS 2030
6.7 Middle East & Africa
6.7.1 Middle East & Africa Dermatology Drug Sales Value (2019-2030)
6.7.2 Middle East & Africa Dermatology Drug Sales Value Share by Country, 2023 VS 2030
7 DERMATOLOGY DRUG MARKET BY COUNTRY
7.1 Global Dermatology Drug Sales Value by Country: 2019 VS 2023 VS 2030
7.2 Global Dermatology Drug Sales Value by Country (2019-2030)
7.2.1 Global Dermatology Drug Sales Value by Country (2019-2024)
7.2.2 Global Dermatology Drug Sales Value by Country (2025-2030)
7.3 USA
7.3.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.3.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.3.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.4 Canada
7.4.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.4.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.4.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.5 Germany
7.5.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.5.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.6 France
7.6.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.6.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.7 U.K.
7.7.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.7.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.8 Italy
7.8.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.8.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.9 Netherlands
7.9.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.9.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.10 Nordic Countries
7.10.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.10.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.11 China
7.11.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.11.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.12 Japan
7.12.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.12.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.13 South Korea
7.13.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.13.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.14 Southeast Asia
7.14.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.14.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.15 India
7.15.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.15.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.16 Australia
7.16.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.16.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.17 Mexico
7.17.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.17.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.18 Brazil
7.18.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.18.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.19 Turkey
7.19.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.19.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.20 Saudi Arabia
7.20.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.20.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
7.21 UAE
7.21.1 Global Dermatology Drug Sales Value Growth Rate (2019-2030)
7.21.2 Global Dermatology Drug Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Dermatology Drug Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 AbbVie
8.1.1 AbbVie Comapny Information
8.1.2 AbbVie Business Overview
8.1.3 AbbVie Dermatology Drug Revenue and Gross Margin (2019-2024)
8.1.4 AbbVie Dermatology Drug Product Portfolio
8.1.5 AbbVie Recent Developments
8.2 Johnson & Johnson
8.2.1 Johnson & Johnson Comapny Information
8.2.2 Johnson & Johnson Business Overview
8.2.3 Johnson & Johnson Dermatology Drug Revenue and Gross Margin (2019-2024)
8.2.4 Johnson & Johnson Dermatology Drug Product Portfolio
8.2.5 Johnson & Johnson Recent Developments
8.3 Bayer
8.3.1 Bayer Comapny Information
8.3.2 Bayer Business Overview
8.3.3 Bayer Dermatology Drug Revenue and Gross Margin (2019-2024)
8.3.4 Bayer Dermatology Drug Product Portfolio
8.3.5 Bayer Recent Developments
8.4 Galderma
8.4.1 Galderma Comapny Information
8.4.2 Galderma Business Overview
8.4.3 Galderma Dermatology Drug Revenue and Gross Margin (2019-2024)
8.4.4 Galderma Dermatology Drug Product Portfolio
8.4.5 Galderma Recent Developments
8.5 Bristol-Myers Squibb
8.5.1 Bristol-Myers Squibb Comapny Information
8.5.2 Bristol-Myers Squibb Business Overview
8.5.3 Bristol-Myers Squibb Dermatology Drug Revenue and Gross Margin (2019-2024)
8.5.4 Bristol-Myers Squibb Dermatology Drug Product Portfolio
8.5.5 Bristol-Myers Squibb Recent Developments
8.6 Novartis
8.6.1 Novartis Comapny Information
8.6.2 Novartis Business Overview
8.6.3 Novartis Dermatology Drug Revenue and Gross Margin (2019-2024)
8.6.4 Novartis Dermatology Drug Product Portfolio
8.6.5 Novartis Recent Developments
8.7 Pfizer
8.7.1 Pfizer Comapny Information
8.7.2 Pfizer Business Overview
8.7.3 Pfizer Dermatology Drug Revenue and Gross Margin (2019-2024)
8.7.4 Pfizer Dermatology Drug Product Portfolio
8.7.5 Pfizer Recent Developments
8.8 Merz Pharma
8.8.1 Merz Pharma Comapny Information
8.8.2 Merz Pharma Business Overview
8.8.3 Merz Pharma Dermatology Drug Revenue and Gross Margin (2019-2024)
8.8.4 Merz Pharma Dermatology Drug Product Portfolio
8.8.5 Merz Pharma Recent Developments
8.9 Valeant
8.9.1 Valeant Comapny Information
8.9.2 Valeant Business Overview
8.9.3 Valeant Dermatology Drug Revenue and Gross Margin (2019-2024)
8.9.4 Valeant Dermatology Drug Product Portfolio
8.9.5 Valeant Recent Developments
8.10 LEO Pharma
8.10.1 LEO Pharma Comapny Information
8.10.2 LEO Pharma Business Overview
8.10.3 LEO Pharma Dermatology Drug Revenue and Gross Margin (2019-2024)
8.10.4 LEO Pharma Dermatology Drug Product Portfolio
8.10.5 LEO Pharma Recent Developments
8.11 GlaxoSmithKline
8.11.1 GlaxoSmithKline Comapny Information
8.11.2 GlaxoSmithKline Business Overview
8.11.3 GlaxoSmithKline Dermatology Drug Revenue and Gross Margin (2019-2024)
8.11.4 GlaxoSmithKline Dermatology Drug Product Portfolio
8.11.5 GlaxoSmithKline Recent Developments
9 CONCLUDING INSIGHTS
10 APPENDIX
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
LIST OF TABLES
Table 1. Dermatology Drug Industry Trends
Table 2. Dermatology Drug Industry Drivers
Table 3. Dermatology Drug Industry Opportunities and Challenges
Table 4. Dermatology Drug Industry Restraints
Table 5. Global Dermatology Drug Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Dermatology Drug Revenue Share by Company (2019-2024)
Table 7. Global Dermatology Drug Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 8. Global Dermatology Drug Key Company Manufacturing Base & Headquarters
Table 9. Global Dermatology Drug Company, Product Type & Application
Table 10. Global Dermatology Drug Company Commercialization Time
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Dermatology Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Major Companies of External Use
Table 15. Major Companies of Oral
Table 16. Major Companies of Injection
Table 17. Global Dermatology Drug Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 18. Global Dermatology Drug Sales Value by Type (2019-2024) & (US$ Million)
Table 19. Global Dermatology Drug Sales Value by Type (2025-2030) & (US$ Million)
Table 20. Global Dermatology Drug Sales Value Share by Type (2019-2024)
Table 21. Global Dermatology Drug Sales Value Share by Type (2025-2030)
Table 22. Major Companies of Psoriasis
Table 23. Major Companies of Skin Infections
Table 24. Major Companies of Acne
Table 25. Major Companies of Dermatitis
Table 26. Major Companies of Others
Table 27. Global Dermatology Drug Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 28. Global Dermatology Drug Sales Value by Application (2019-2024) & (US$ Million)
Table 29. Global Dermatology Drug Sales Value by Application (2025-2030) & (US$ Million)
Table 30. Global Dermatology Drug Sales Value Share by Application (2019-2024)
Table 31. Global Dermatology Drug Sales Value Share by Application (2025-2030)
Table 32. Global Dermatology Drug Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 33. Global Dermatology Drug Sales Value by Region (2019-2024) & (US$ Million)
Table 34. Global Dermatology Drug Sales Value Share by Region (2019-2024)
Table 35. Global Dermatology Drug Sales Value by Region (2025-2030) & (US$ Million)
Table 36. Global Dermatology Drug Sales Value Share by Region (2025-2030)
Table 37. Global Dermatology Drug Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 38. Global Dermatology Drug Sales Value by Country (2019-2024) & (US$ Million)
Table 39. Global Dermatology Drug Sales Value Market Share by Country (2019-2024)
Table 40. Global Dermatology Drug Sales Value by Country (2025-2030) & (US$ Million)
Table 41. Global Dermatology Drug Sales Value Market Share by Country (2025-2030)
Table 42. AbbVie Company Information
Table 43. AbbVie Business Overview
Table 44. AbbVie Dermatology Drug Revenue (US$ Million) and Gross Margin (2019-2024)
Table 45. AbbVie Dermatology Drug Product Portfolio
Table 46. AbbVie Recent Development
Table 47. Johnson & Johnson Company Information
Table 48. Johnson & Johnson Business Overview
Table 49. Johnson & Johnson Dermatology Drug Revenue (US$ Million) and Gross Margin (2019-2024)
Table 50. Johnson & Johnson Dermatology Drug Product Portfolio
Table 51. Johnson & Johnson Recent Development
Table 52. Bayer Company Information
Table 53. Bayer Business Overview
Table 54. Bayer Dermatology Drug Revenue (US$ Million) and Gross Margin (2019-2024)
Table 55. Bayer Dermatology Drug Product Portfolio
Table 56. Bayer Recent Development
Table 57. Galderma Company Information
Table 58. Galderma Business Overview
Table 59. Galderma Dermatology Drug Revenue (US$ Million) and Gross Margin (2019-2024)
Table 60. Galderma Dermatology Drug Product Portfolio
Table 61. Galderma Recent Development
Table 62. Bristol-Myers Squibb Company Information
Table 63. Bristol-Myers Squibb Business Overview
Table 64. Bristol-Myers Squibb Dermatology Drug Revenue (US$ Million) and Gross Margin (2019-2024)
Table 65. Bristol-Myers Squibb Dermatology Drug Product Portfolio
Table 66. Bristol-Myers Squibb Recent Development
Table 67. Novartis Company Information
Table 68. Novartis Business Overview
Table 69. Novartis Dermatology Drug Revenue (US$ Million) and Gross Margin (2019-2024)
Table 70. Novartis Dermatology Drug Product Portfolio
Table 71. Novartis Recent Development
Table 72. Pfizer Company Information
Table 73. Pfizer Business Overview
Table 74. Pfizer Dermatology Drug Revenue (US$ Million) and Gross Margin (2019-2024)
Table 75. Pfizer Dermatology Drug Product Portfolio
Table 76. Pfizer Recent Development
Table 77. Merz Pharma Company Information
Table 78. Merz Pharma Business Overview
Table 79. Merz Pharma Dermatology Drug Revenue (US$ Million) and Gross Margin (2019-2024)
Table 80. Merz Pharma Dermatology Drug Product Portfolio
Table 81. Merz Pharma Recent Development
Table 82. Valeant Company Information
Table 83. Valeant Business Overview
Table 84. Valeant Dermatology Drug Revenue (US$ Million) and Gross Margin (2019-2024)
Table 85. Valeant Dermatology Drug Product Portfolio
Table 86. Valeant Recent Development
Table 87. LEO Pharma Company Information
Table 88. LEO Pharma Business Overview
Table 89. LEO Pharma Dermatology Drug Revenue (US$ Million) and Gross Margin (2019-2024)
Table 90. LEO Pharma Dermatology Drug Product Portfolio
Table 91. LEO Pharma Recent Development
Table 92. GlaxoSmithKline Company Information
Table 93. GlaxoSmithKline Business Overview
Table 94. GlaxoSmithKline Dermatology Drug Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 95. GlaxoSmithKline Dermatology Drug Product Portfolio
Table 96. GlaxoSmithKline Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Authors List of This Report
Table 99. Secondary Sources
Table 100. Primary Sources
Table 1. Dermatology Drug Industry Trends
Table 2. Dermatology Drug Industry Drivers
Table 3. Dermatology Drug Industry Opportunities and Challenges
Table 4. Dermatology Drug Industry Restraints
Table 5. Global Dermatology Drug Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Dermatology Drug Revenue Share by Company (2019-2024)
Table 7. Global Dermatology Drug Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 8. Global Dermatology Drug Key Company Manufacturing Base & Headquarters
Table 9. Global Dermatology Drug Company, Product Type & Application
Table 10. Global Dermatology Drug Company Commercialization Time
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Dermatology Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Major Companies of External Use
Table 15. Major Companies of Oral
Table 16. Major Companies of Injection
Table 17. Global Dermatology Drug Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 18. Global Dermatology Drug Sales Value by Type (2019-2024) & (US$ Million)
Table 19. Global Dermatology Drug Sales Value by Type (2025-2030) & (US$ Million)
Table 20. Global Dermatology Drug Sales Value Share by Type (2019-2024)
Table 21. Global Dermatology Drug Sales Value Share by Type (2025-2030)
Table 22. Major Companies of Psoriasis
Table 23. Major Companies of Skin Infections
Table 24. Major Companies of Acne
Table 25. Major Companies of Dermatitis
Table 26. Major Companies of Others
Table 27. Global Dermatology Drug Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 28. Global Dermatology Drug Sales Value by Application (2019-2024) & (US$ Million)
Table 29. Global Dermatology Drug Sales Value by Application (2025-2030) & (US$ Million)
Table 30. Global Dermatology Drug Sales Value Share by Application (2019-2024)
Table 31. Global Dermatology Drug Sales Value Share by Application (2025-2030)
Table 32. Global Dermatology Drug Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 33. Global Dermatology Drug Sales Value by Region (2019-2024) & (US$ Million)
Table 34. Global Dermatology Drug Sales Value Share by Region (2019-2024)
Table 35. Global Dermatology Drug Sales Value by Region (2025-2030) & (US$ Million)
Table 36. Global Dermatology Drug Sales Value Share by Region (2025-2030)
Table 37. Global Dermatology Drug Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 38. Global Dermatology Drug Sales Value by Country (2019-2024) & (US$ Million)
Table 39. Global Dermatology Drug Sales Value Market Share by Country (2019-2024)
Table 40. Global Dermatology Drug Sales Value by Country (2025-2030) & (US$ Million)
Table 41. Global Dermatology Drug Sales Value Market Share by Country (2025-2030)
Table 42. AbbVie Company Information
Table 43. AbbVie Business Overview
Table 44. AbbVie Dermatology Drug Revenue (US$ Million) and Gross Margin (2019-2024)
Table 45. AbbVie Dermatology Drug Product Portfolio
Table 46. AbbVie Recent Development
Table 47. Johnson & Johnson Company Information
Table 48. Johnson & Johnson Business Overview
Table 49. Johnson & Johnson Dermatology Drug Revenue (US$ Million) and Gross Margin (2019-2024)
Table 50. Johnson & Johnson Dermatology Drug Product Portfolio
Table 51. Johnson & Johnson Recent Development
Table 52. Bayer Company Information
Table 53. Bayer Business Overview
Table 54. Bayer Dermatology Drug Revenue (US$ Million) and Gross Margin (2019-2024)
Table 55. Bayer Dermatology Drug Product Portfolio
Table 56. Bayer Recent Development
Table 57. Galderma Company Information
Table 58. Galderma Business Overview
Table 59. Galderma Dermatology Drug Revenue (US$ Million) and Gross Margin (2019-2024)
Table 60. Galderma Dermatology Drug Product Portfolio
Table 61. Galderma Recent Development
Table 62. Bristol-Myers Squibb Company Information
Table 63. Bristol-Myers Squibb Business Overview
Table 64. Bristol-Myers Squibb Dermatology Drug Revenue (US$ Million) and Gross Margin (2019-2024)
Table 65. Bristol-Myers Squibb Dermatology Drug Product Portfolio
Table 66. Bristol-Myers Squibb Recent Development
Table 67. Novartis Company Information
Table 68. Novartis Business Overview
Table 69. Novartis Dermatology Drug Revenue (US$ Million) and Gross Margin (2019-2024)
Table 70. Novartis Dermatology Drug Product Portfolio
Table 71. Novartis Recent Development
Table 72. Pfizer Company Information
Table 73. Pfizer Business Overview
Table 74. Pfizer Dermatology Drug Revenue (US$ Million) and Gross Margin (2019-2024)
Table 75. Pfizer Dermatology Drug Product Portfolio
Table 76. Pfizer Recent Development
Table 77. Merz Pharma Company Information
Table 78. Merz Pharma Business Overview
Table 79. Merz Pharma Dermatology Drug Revenue (US$ Million) and Gross Margin (2019-2024)
Table 80. Merz Pharma Dermatology Drug Product Portfolio
Table 81. Merz Pharma Recent Development
Table 82. Valeant Company Information
Table 83. Valeant Business Overview
Table 84. Valeant Dermatology Drug Revenue (US$ Million) and Gross Margin (2019-2024)
Table 85. Valeant Dermatology Drug Product Portfolio
Table 86. Valeant Recent Development
Table 87. LEO Pharma Company Information
Table 88. LEO Pharma Business Overview
Table 89. LEO Pharma Dermatology Drug Revenue (US$ Million) and Gross Margin (2019-2024)
Table 90. LEO Pharma Dermatology Drug Product Portfolio
Table 91. LEO Pharma Recent Development
Table 92. GlaxoSmithKline Company Information
Table 93. GlaxoSmithKline Business Overview
Table 94. GlaxoSmithKline Dermatology Drug Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 95. GlaxoSmithKline Dermatology Drug Product Portfolio
Table 96. GlaxoSmithKline Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Authors List of This Report
Table 99. Secondary Sources
Table 100. Primary Sources
LIST OF FIGURES
Figure 1. Dermatology Drug Product Picture
Figure 2. Global Dermatology Drug Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Dermatology Drug Market Size (2019-2030) & (US$ Million)
Figure 4. Global Dermatology Drug Company Revenue Ranking in 2023 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 7. External Use Picture
Figure 8. Oral Picture
Figure 9. Injection Picture
Figure 10. Global Dermatology Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Dermatology Drug Sales Value Share 2019 VS 2023 VS 2030
Figure 12. Global Dermatology Drug Sales Value Share by Type (2019-2030)
Figure 13. Psoriasis Picture
Figure 14. Skin Infections Picture
Figure 15. Acne Picture
Figure 16. Dermatitis Picture
Figure 17. Others Picture
Figure 18. Global Dermatology Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Dermatology Drug Sales Value Share 2019 VS 2023 VS 2030
Figure 20. Global Dermatology Drug Sales Value Share by Application (2019-2030)
Figure 21. Global Dermatology Drug Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 22. Global Dermatology Drug Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 23. North America Dermatology Drug Sales Value (2019-2030) & (US$ Million)
Figure 24. North America Dermatology Drug Sales Value Share by Country (%), 2023 VS 2030
Figure 25. Europe Dermatology Drug Sales Value (2019-2030) & (US$ Million)
Figure 26. Europe Dermatology Drug Sales Value Share by Country (%), 2023 VS 2030
Figure 27. Asia-Pacific Dermatology Drug Sales Value (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Dermatology Drug Sales Value Share by Country (%), 2023 VS 2030
Figure 29. Latin America Dermatology Drug Sales Value (2019-2030) & (US$ Million)
Figure 30. Latin America Dermatology Drug Sales Value Share by Country (%), 2023 VS 2030
Figure 31. Middle East & Africa Dermatology Drug Sales Value (2019-2030) & (US$ Million)
Figure 32. Middle East & Africa Dermatology Drug Sales Value Share by Country (%), 2023 VS 2030
Figure 33. USA Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 34. USA Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 35. USA Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 36. Canada Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 37. Canada Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 38. Canada Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 39. Germany Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 40. Germany Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 41. Germany Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 42. France Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 43. France Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 44. France Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 45. U.K. Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 46. U.K. Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 47. U.K. Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 48. Italy Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 49. Italy Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 50. Italy Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 51. Netherlands Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 52. Netherlands Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 53. Netherlands Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 54. Nordic Countries Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 55. Nordic Countries Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 56. Nordic Countries Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 57. China Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 58. China Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 59. China Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 60. Japan Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 61. Japan Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 62. Japan Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 63. South Korea Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 64. South Korea Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 65. South Korea Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 66. Southeast Asia Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 67. Southeast Asia Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 68. Southeast Asia Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 69. India Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 70. India Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 71. India Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 72. Australia Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 73. Australia Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 74. Australia Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 75. Mexico Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 76. Mexico Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 77. Mexico Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 78. Brazil Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 79. Brazil Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 80. Brazil Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 81. Turkey Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 82. Turkey Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 83. Turkey Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 84. Saudi Arabia Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 85. Saudi Arabia Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 86. Saudi Arabia Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 87. UAE Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 88. UAE Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 89. UAE Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 90. Years Considered
Figure 91. Research Process
Figure 92. Key Executives Interviewed
Figure 1. Dermatology Drug Product Picture
Figure 2. Global Dermatology Drug Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Dermatology Drug Market Size (2019-2030) & (US$ Million)
Figure 4. Global Dermatology Drug Company Revenue Ranking in 2023 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 7. External Use Picture
Figure 8. Oral Picture
Figure 9. Injection Picture
Figure 10. Global Dermatology Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Dermatology Drug Sales Value Share 2019 VS 2023 VS 2030
Figure 12. Global Dermatology Drug Sales Value Share by Type (2019-2030)
Figure 13. Psoriasis Picture
Figure 14. Skin Infections Picture
Figure 15. Acne Picture
Figure 16. Dermatitis Picture
Figure 17. Others Picture
Figure 18. Global Dermatology Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Dermatology Drug Sales Value Share 2019 VS 2023 VS 2030
Figure 20. Global Dermatology Drug Sales Value Share by Application (2019-2030)
Figure 21. Global Dermatology Drug Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 22. Global Dermatology Drug Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 23. North America Dermatology Drug Sales Value (2019-2030) & (US$ Million)
Figure 24. North America Dermatology Drug Sales Value Share by Country (%), 2023 VS 2030
Figure 25. Europe Dermatology Drug Sales Value (2019-2030) & (US$ Million)
Figure 26. Europe Dermatology Drug Sales Value Share by Country (%), 2023 VS 2030
Figure 27. Asia-Pacific Dermatology Drug Sales Value (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Dermatology Drug Sales Value Share by Country (%), 2023 VS 2030
Figure 29. Latin America Dermatology Drug Sales Value (2019-2030) & (US$ Million)
Figure 30. Latin America Dermatology Drug Sales Value Share by Country (%), 2023 VS 2030
Figure 31. Middle East & Africa Dermatology Drug Sales Value (2019-2030) & (US$ Million)
Figure 32. Middle East & Africa Dermatology Drug Sales Value Share by Country (%), 2023 VS 2030
Figure 33. USA Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 34. USA Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 35. USA Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 36. Canada Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 37. Canada Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 38. Canada Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 39. Germany Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 40. Germany Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 41. Germany Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 42. France Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 43. France Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 44. France Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 45. U.K. Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 46. U.K. Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 47. U.K. Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 48. Italy Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 49. Italy Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 50. Italy Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 51. Netherlands Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 52. Netherlands Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 53. Netherlands Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 54. Nordic Countries Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 55. Nordic Countries Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 56. Nordic Countries Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 57. China Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 58. China Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 59. China Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 60. Japan Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 61. Japan Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 62. Japan Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 63. South Korea Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 64. South Korea Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 65. South Korea Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 66. Southeast Asia Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 67. Southeast Asia Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 68. Southeast Asia Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 69. India Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 70. India Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 71. India Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 72. Australia Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 73. Australia Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 74. Australia Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 75. Mexico Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 76. Mexico Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 77. Mexico Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 78. Brazil Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 79. Brazil Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 80. Brazil Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 81. Turkey Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 82. Turkey Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 83. Turkey Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 84. Saudi Arabia Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 85. Saudi Arabia Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 86. Saudi Arabia Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 87. UAE Dermatology Drug Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 88. UAE Dermatology Drug Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 89. UAE Dermatology Drug Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 90. Years Considered
Figure 91. Research Process
Figure 92. Key Executives Interviewed
